Researchers interviewed professional medical interpreters, sharing some of the lessons they learned in JACC: Heart Failure.

Sex-linked variations in the RAP1GAP2 gene could help explain poor outcomes for women with heart disease. 

Devi Nair, MD, director of cardiac electrophysiology at St. Bernard's Healthcare, Jonesboro, Arkansas, explains some of the recent advances in transcatheter left atrial appendage (LAA) occlusion technology at the 2022 Transcatheter Valve Therapeutics (TVT) Structural Heart Summit.

TAVR patients with gastrointestinal bleeding (GIB) were linked to longer lengths of stay and a higher risk of acute kidney injury than patients without GIB.

Doctors involved with the historic procedure shared key details about their experience in the New England Journal of Medicine.

The FDA had a busy June, clearing multiple solutions designed to treat patients with cardiovascular conditions. 

A Hong Kong study examined incidence rate ratios for major adverse cardiovascular events in the 27 days following each vaccine dose. 

It was clear at TVT that tricuspid valve therapies will likely move ahead of new mitral therapies coming to market. Azeem Latib, MD, explained why.

In wake of the Supreme Court’s vote to overturn Roe v. Wade––the historic court case that set a precedent for the Constitutional right to abortion care for the last nearly 50 years––healthcare industry groups and leaders have come forward speaking out against the decision.